Beckman Coulter MicroScan B1016-138 Manuel D'utilisation page 8

Antimicrobics
8
Chloramphenicol
Staphylococci and Enterococci
β-hemolytic Streptococci (S. agalactiae, Group B)
Viridans Group Streptococci (S. bovis group)
Ciprofloxacin
Staphylococci
Enterococci
8
Clarithromycin
Staphylococci
8
Clindamycin
Staphylococci
β-hemolytic Streptococci (S. agalactiae, Group B)
Viridans Group Streptococci (S. bovis group)
Daptomycin
6
Staphylococci
6
Enterococci
β-hemolytic Streptococci (S. agalactiae, Group B)
Viridans Group Streptococci (S. bovis group)
5
Ertapenem
Staphylococci (CLSI M100-S22)
β-hemolytic Streptococci (S. agalactiae, Group B)
8
Erythromycin
Staphylococci
Enterococci
β-hemolytic Streptococci (S. agalactiae, Group B)
Fosfomycin – Staphylococci
9
Fusidic Acid
Staphylococci
10
Gatifloxacin
Staphylococci
Gentamicin – Staphylococci
5
Imipenem
Staphylococci (CLSI M100-S22)
Enterococci
9
Kanamycin
Staphylococci
Levofloxacin
Staphylococci
Enterococci
β-hemolytic Streptococci (S. agalactiae, Group B)
Viridans Group Streptococci (S. bovis group)
9
Lincomycin
Staphylococci, Enterococci,
β-hemolytic Streptococci (S. agalactiae, Group B), and
Viridans Group Streptococci (S. bovis group)
Linezolid
Staphylococci
Enterococci
β-hemolytic Streptococci (S. agalactiae, Group B)
Viridans Group Streptococci (S. bovis group)
5,8
Meropenem
Staphylococci (CLSI M100-S22)
Minocycline
Staphylococci
Enterococci
8
Moxifloxacin
10
Staphylococci
11
Staphylococci
11
Enterococci
7
Mupirocin
Staphylococci (topical)
Staphylococci (nasal)
Netilmicin – Staphylococci
12
Nitrofurantoin
Staphylococci and Enterococci
12
Norfloxacin
Staphylococci and Enterococci
C29870–AD
Abbr.
C
Cp
≤1
Cla
≤1
Cd
≤0.25
Dap
≤1
6
≤1
6
Etp
6
E
≤1
≤0.25
Fos ≤32
FA
Gat
Gm ≤1
Imp
≤4
K
Lvx
≤1
≤1
Lin
Lzd
≤4
≤4
6
≤2
6
Mer
Min
≤0.5
Mxf
≤0.5
Mup
Nt
Fd
≤64
Nxn
8 of 339
1
EUCAST
S I R S
- - -
≤8
- - -
≤4
- - -
≤4
-
>1 ≤1
- - -
≤1
2 >2 ≤2
0.5 >0.5 ≤0.5
- - -
≤0.25
- - -
≤0.25
-
>1 ≤1
- - -
≤4
-
>1 ≤1
- - -
≤1
- - -
≤2
- - -
≤1
2 >2 ≤0.5
- - -
≤0.5
0.5 >0.5 ≤0.25
- -
>32
- - - -
- - - -
-
>1 ≤4
- - -
≤4
-
8 >8
- - - -
2 >2 ≤1
- - -
≤2
2 >2 ≤2
- - -
≤2
- - - -
-
>4 ≤4
-
>4 ≤2
4 >4 ≤2
- - -
≤2
- - -
≤4
1 >1 ≤4
- - -
≤4
-
1 >1
- - - -
- - - -
- - - -
- - - -
- - -
≤8
-
>64 ≤32
- - -
≤4
2
CLSI OTHER
I R S
-
16 ≥32
-
8 ≥16
-
8 ≥16
-
2 ≥4
-
2 ≥4
-
4 ≥8
-
1-2 ≥4
-
0.5 ≥1
-
0.5 ≥1
- - -
- - -
- - -
- - -
-
4 ≥8
- - -
-
1-4 ≥8
-
1-4 ≥8
-
0.5 ≥1
- - -
- -
≤2
- -
≤2
-
8 ≥16
-
8 ≥16
- - -
- -
≤8
-
2 ≥4
-
4 ≥8
-
4 ≥8
-
4 ≥8
- -
≤2 4-8
- -
≥8
-
4 ≥8
- - -
- - -
-
8 ≥16
-
8 ≥16
-
8 ≥16
- -
≤2
- -
≤0.12 0.5-2
- -
≤0.5 1-2
- -
≤4
- -
≤256
-
16 ≥32
-
64 ≥128
-
8 ≥16
3
I R
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
16 ≥32
4 ≥8
- -
- -
- -
16 ≥32
- -
- -
- -
- -
≥16
- -
- -
- -
- -
- -
- -
- -
4 ≥8
≥4
≥4
-
≥8
-
≥512
- -
- -
- -